Liposomal antifungal agents workshop

FDA/National Institute of Allergy and Infectious Diseases workshop April 20 will focus on design of trials for liposome encapsulated drug products. The workshop will discuss "whether and how to conduct active-controlled trials of the liposomal drug... and whether the use of historical controls might be justified in some cases, and if so, how historical control data might be collected for specific fungal infections." The meeting will be held from 1 p.m. to 5 p.m. in conference room G of FDA's Parklawn building